CD44 cell adhesion molecules

被引:4
作者
Goodison, S
Urquidi, V
Tarin, D
机构
[1] Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA
来源
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY | 1999年 / 52卷 / 04期
关键词
CD44; structure; hyaluronic acid; alternative splicing; neoplasia;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The CD44 proteins form a ubiquitously expressed family of cell surface adhesion molecules involved in cell-cell and cell-matrix interactions. The multiple protein isoforms are encoded by a single gene by alternative splicing and are further modified by a range of post-translational modifications. CD44 proteins are single chain molecules comprising an N-terminal extracellular domain, a membrane proximal region, a transmembrane domain, and a cytoplasmic tail. The CD44 gene has only been detected in higher organisms and the amino acid sequence of most of the molecule is highly conserved between mammalian species. The principal ligand of CD44 is hyaluronic acid, an integral component of the extracellular matrix. Other CD44 ligands include osteopontin, serglycin, collagens, fibronectin, and laminin. The major physiological role of CD44 is to maintain organ and tissue structure via cell-cell and cell-matrix adhesion, but certain variant isoforms can also mediate lymphocyte activation and homing, and the presentation of chemical factors and hormones. Increased interest has been directed at the characterisation of this molecule since it was observed that expression of multiple CD44 isoforms is greatly upregulated in neoplasia. CD44, particularly its variants, may be useful as a diagnostic or prognostic marker of malignancy and, in at least some human cancers, it may be a potential target for cancer therapy. This review describes the structure of the CD44 gene and discusses some of its roles in physiological and pathological processes.
引用
收藏
页码:189 / 196
页数:8
相关论文
共 122 条
  • [1] AIHO AM, 1989, J CELL BIOL, V108, P1557
  • [2] PARTICIPATION IN NORMAL IMMUNE-RESPONSES OF A METASTASIS-INDUCING SPLICE VARIANT OF CD44
    ARCH, R
    WIRTH, K
    HOFMANN, M
    PONTA, H
    MATZKU, S
    HERRLICH, P
    ZOLLER, M
    [J]. SCIENCE, 1992, 257 (5070) : 682 - 685
  • [3] AYROLDI E, 1995, BLOOD, V86, P2672
  • [4] Identification of CD44 residues important for hyaluronan binding and delineation of the binding site
    Bajorath, J
    Greenfield, B
    Munro, SB
    Day, AJ
    Aruffo, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) : 338 - 343
  • [5] INTERACTION BETWEEN CD44 AND HYALURONATE IS DIRECTLY IMPLICATED IN THE REGULATION OF TUMOR-DEVELOPMENT
    BARTOLAZZI, A
    PEACH, R
    ARUFFO, A
    STAMENKOVIC, I
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) : 53 - 66
  • [6] Engagement of variant CD44 confers resistance to anti-integrin antibody-mediated apoptosis in a colon carcinoma cell line
    Bates, RC
    Elith, CA
    Thorne, RF
    Burns, GF
    [J]. CELL ADHESION AND COMMUNICATION, 1998, 6 (01) : 21 - 38
  • [7] REGULATION OF CD44 BINDING TO HYALURONAN BY GLYCOSYLATION OF VARIABLY SPLICED EXONS
    BENNETT, KL
    MODRELL, B
    GREENFIELD, B
    BARTOLAZZI, A
    STAMENKOVIC, I
    PEACH, R
    JACKSON, DG
    SPRING, F
    ARUFFO, A
    [J]. JOURNAL OF CELL BIOLOGY, 1995, 131 (06) : 1623 - 1633
  • [8] CD44 ISOFORMS CONTAINING EXON V3 ARE RESPONSIBLE FOR THE PRESENTATION OF HEPARIN-BINDING GROWTH-FACTOR
    BENNETT, KL
    JACKSON, DG
    SIMON, JC
    TANCZOS, E
    PEACH, R
    MODRELL, B
    STAMENKOVIC, I
    PLOWMAN, G
    ARUFFO, A
    [J]. JOURNAL OF CELL BIOLOGY, 1995, 128 (04) : 687 - 698
  • [9] BIRCH M, 1991, CANCER RES, V51, P6660
  • [10] CD44 expression in human breast cancer cell lines is related to oestrogen receptor (ER) status and confluency in vitro.
    Bolodeoku, J
    Yoshida, K
    Sugino, T
    Churchman, M
    Woodman, A
    Goodison, S
    Tarin, D
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (02) : S356 - S356